Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo

Molecular Endocrinology

Volumn 13, Issue 6, 1999, Pages 910-924

  Tetel, Marc J ^a,c   Giangrande, Paloma H ^b   Leonhardt, Susan A ^a   McDonnell, Donald P ^b   Edwards, Dean P ^a  

^a UNIVERSITY OF COLORADO   (United States)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c UNIVERSITY OF MASSACHUSETTS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MIFEPRISTONE; PROGESTERONE RECEPTOR; PROMEGESTONE; STEROID RECEPTOR;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ARTICLE; CARBOXY TERMINAL SEQUENCE; MAMMAL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN CONFORMATION; PROTEIN PROTEIN INTERACTION; PROTEIN PURIFICATION; RECEPTOR BINDING; REPRESSOR GENE; TRANSCRIPTION REGULATION;

EID: 0033305373     PISSN: 08888809     EISSN: None     Source Type: Journal    
DOI: 10.1210/mend.13.6.0300     Document Type: Article

References (62)

1. The nuclear receptor superfamily: The second decade
2. Molecular mechanisms of action of steroid/thyroid receptor superfamily members
3. Two distinct estrogen-regulated promoters generate transcripts encoding the two functionally different human progesterone receptor forms
4. Agonistic and antagonistic activities of RU486 on the functions of the human progesterone receptor
5. A limiting factor mediates the differential activation of promoters by the human progesterone receptor isoforms
6. A third transactivation function (AF3) of human progesterone receptors located in the unique N-terminal segment of the B-isoform
7. Human progesterone receptor A form is a cell- and promoter-specific repressor of human progesterone receptor B function
8. RU486 Exerts antiestrogenic activities through a novel progesterone receptor A form-mediated mechanism
9. Antagonist-occupied human progesterone B-receptors activate transcription without binding to progesterone response element and are dominantly inhibited by A-receptors
10. The A and B isoforms of the human progesterone receptor operate through distinct signaling pathways within target cells
11. Mapping and characterization of the functional domains responsible for the differential activity of the A and B isoform of the human progesterone receptors
12. An N-terminal inbitory function, IF, suppresses transcription by the A-isoform but not the B-isoform of human progesterone receptors
13. Steroid receptors and their associated proteins
14. Steroid hormone receptors: Interaction with deoxyribonucleic acid and transcription factors
15. Dimerazation of mammmalian progesterone receptors occurs in the absense of DNA and is related to the release of the 90-kDa heat shock protein
16. Sequence and characterization of a coactivator for the steroid hormone receptor superfamily
17. Role of coregulatory proteins in nuclear receptor action
18. A growing coactivator network
19. p300 Is a component of an estrogen receptor coactivator complex
20. Role of coactivators and corepressors in the mechanism of steroid/thyroid receptor action
21. The transcriptional coactivator p/CIP binds CBP and mediates nuclear-receptor function
22. A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors
23. Partial hormone resistance in mice with disruption of the steroid receptor coactivator-1 (SRC-1) gene
24. Steroid receptor induction of gene transcription: A two step model
25. Steroid receptor coactivator-1 is a histone acetyltransferase
26. Nuclear receptor coactivator ACTR is anovel histone acetyltransferase and foms a multimeric activation complex with P/CAF and CBP/p300
27. Transcription factor-specific requirements for coactivators and their acetyltransferase functions
28. The steriod receptor coactivator-1 contains multiple receptor interacting and activation domains that cooperatively enhance the activation function 1 (AF1) and AF2 domains of steroid receptofs
29. Coactivator and corepressor regulation of the agonist/antagonist activity of the mixed antiestrogen, 4-hydroxytamoxifen
30. Interaction between the amino- and carboxyl-terminal regions of the rat androgen receptor modulates transcriptional activity and is influenced by nuclear receptor coactivators
31. Estrogen receptor activation function 1 works by binding p160 coactivator proteins
32. The human estrogen receptor has two independent non-acidic transcriptional activation functions
33. Identification of two transactivation domains in the mouse oestrogen receptor
34. Characterization of the amino-terminal transcriptional activation function of the human estrogen receptor in animal and yeast cells
35. The contribution of the N- and C-terminal regions of steroid receptors to activation of transcription is both receptor- and cell-specific
36. Distinct classes of transcriptional activating domains function by different mechanisms
37. Functional domains of the human estrogen receptor
38. Human estrogen receptor transactivational capacity is determined by both cellular and promoter context and mediated by two functionally distinct intramolecular regions
39. Ligand-dependent and ligand-independent function of the transactivation regions of the human estrogen receptor in yeast
40. Ligand-dependent, transcriptionally productive association of the amino- and carboxyl-terminal regions of a steroid hormone nuclear receptor
41. Evidence for an anti-parallel orientation of the ligand-activated human androgen receptor dimer
42. Functional in vivo interaction between the amino-terminal, transactivation domain and the ligand binding domain of the androgen receptor
43. Functional interaction of the AF-2 cativation domain core region of the human androgen receptor with the amino-terminal domain and with the transcriptional coactivator TIF2 (transcriptional intermediary factor 2)
44. Analysis of estrogen receptor transcriptional enhancement by a nuclear hormone receptor coactivator
45. Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor
46. Immunological analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies
47. Ligands induce conformational change in the caboxyl-terminus of progesterone receptors which are detected by a site-diercted antipeptide monoclonal antibody
48. Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II
49. Adenoviral E1A-associated protein p300 as a functional homologue of the transcriptional co-activator CBP
50. Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation
51. Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system
52. Transcriptional activation by the estrogen receptor requires a conformational change in the ligand binding domain
53. Agonists, but not antagonists, alter the conformation of the hormone-binding domain of androgen receptor
54. Intermolecular NH2-/carboxyl-terminal interactions in androgen receptor dimerization revealed by mutations that cause androgen insensitivity
55. Specific binding of progesterone receptor to progesterone response elements does not require prior dimerization
56. The leucine zippers of c-fos and c-jun for progesterone receptor dimerization: A-dominance in the A/B heterodimer
57. Atomic structure of progesterone complexed with its receptor
58. Functional properties and post-translational modification of steroid hormone receptors in the baculovirus expression system
59. High-mobility group chromatin protein 1 and 2 functionally interact with steroid hormone receptors to enhance their DNA binding in vitro and transcriptioanl activity in mammalian cells
60. Nuclear protein CBP is a coactivator for the transcription factor CREB
61. Construction of plasmids that express E. coli β-galactosidase in mammalian cells
62. Identification of a new subclass of alu repeats which can function as estrogen receptor-dependent transcriptional enhancers